Hezong Medicine Easy-To-Buy Pharmaceutical: Hainan Hesen and Chengdu Heqi plan to transfer 2.469 million shares, accounting for 2.58% of the total share capital

Hezong Medicine Easy-To-Buy Pharmaceutical announced that shareholders Hainan Hesen and Chengdu Heqi plan to transfer 2.469 million shares, accounting for 2.58% of the total share capital. This inquiry transfer is a non-public transfer, and the transferee is an institutional investor with corresponding pricing ability and risk tolerance, and the shares cannot be transferred within 6 months after the transfer. The reason for the transfer is the need for self-funding and to improve the shareholder structure, which will help the company attract long-term institutional investors and enhance governance capabilities